FOR PATIENTS
CONTACT
EN
IT
About us
Team
Investors
Ethical code of conduct
Organisational structure
Therapeutic focus
Our Platform
Drug Delivery Platform
Pipeline
Background Science
Clinical Programs
NP-MP1
News & Events
Press releases
Events Attending
Financial Declarations
Careers
Vacancies
Values
Press releases
22 May 2022
NanoPhoria receives a 3.5M€ seed grant from Sofinnova Partners a leading European life sciences venture capital firm based in Paris, London and Milan
BACK